Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. reports developments tied to healthcare intelligence, data and analytics technology, and professional services for healthcare organizations. Company updates commonly cover operating results, revenue and Adjusted EBITDA guidance, and the use of AI-driven technology and domain expertise to support health systems across cost, clinical, and consumer performance.
Recurring news also includes leadership and board governance changes, shareholder-related board appointments, investor conference participation, and updates on strategic focus areas for its healthcare data platform, analytics applications, implementation, advisory, outsourcing, and improvement services.
Health Enterprise Partners (HEP) announced five realizations of portfolio companies and a new investment in Kno2, marking its tenth platform investment from HEP III. HEP focuses on founder-financed businesses, having previously invested in Twistle, which enhances patient engagement in healthcare. Health Catalyst (NASDAQ: HCAT) disclosed its acquisition of Twistle, enhancing its data and analytics services. Privia Health (NASDAQ: PRVA) completed a successful IPO, raising approximately $131.7 million. HEP's new investment in Kno2 will support interoperability in healthcare, aiming for better patient information exchange.
Health Catalyst (Nasdaq: HCAT) announced a definitive agreement to acquire Twistle, a patient engagement SaaS company based in Albuquerque, New Mexico. The acquisition aims to enhance patient-centered communication and improve healthcare outcomes by integrating Twistle’s workflow technology with Health Catalyst's data platform, DOS™. The transaction is expected to close in early Q3 2021 and will be funded through a mix of stock and cash. The synergy aims to drive better care and reduce costs, aligning with Health Catalyst's mission to leverage data for healthcare improvements.
Health Catalyst, a key player in data and analytics for healthcare, announced participation in the 41st Annual William Blair Growth Stock Conference on June 2, 2021, at 5:40 p.m. ET. CEO Dan Burton and SVP Adam Brown will engage in a fireside chat during the event. A webcast will be accessible via their investor relations page. Health Catalyst empowers healthcare organizations with cloud-based data platforms, utilizing insights from over 100 million patient records to enhance clinical, financial, and operational outcomes, ultimately striving for data-informed healthcare decisions.
Health Catalyst (Nasdaq: HCAT) reported a 24% increase in total revenue for Q1 2021, reaching $55.846 million compared to $45.116 million in Q1 2020. Technology revenue grew 37% to $33.839 million, while professional services revenue rose 8% to $22.007 million. Despite this growth, the company experienced a 62% increase in net loss, totaling $(28.370 million). Adjusted EBITDA improved by 86% to $(837,000). Employee satisfaction remains high, with scores in the 96th percentile. The company continues to navigate challenges from the pandemic while integrating new team members.
Health Catalyst, Inc. (Nasdaq: HCAT) will report its Q1 2021 operating results on May 6, 2021, after market close. The company also plans to host a conference call at 5 p.m. E.T. to discuss these results. Participants can access the call by dialing in or through a live audio webcast available on the company's investor relations website. The replay of the conference call will be accessible for approximately 90 days. Health Catalyst provides data and analytics technology aimed at improving healthcare outcomes.
Health Catalyst, Inc. (NASDAQ: HCAT) announced that its CEO, Dan Burton, was honored as "CEO of the Year 2021" by Utah Business. The recognition acknowledges leaders who exhibit strength and impact within their organizations. Under Burton's guidance, Health Catalyst evolved into a multibillion-dollar entity, achieving significant growth despite the pandemic. The company maintained its workforce, acquired three tech firms, and enhanced its product offerings, including nine COVID-specific capabilities. Since its IPO in July 2019, Health Catalyst has consistently ranked high in employee engagement metrics.
Health Catalyst launched Healthcare.AI, a suite of AI products and services aimed at addressing challenges in revenue, cost, and quality within healthcare organizations. The suite expands AI use cases, featuring five levels of analytics. It allows easy integration into existing tools and significantly reduces the time required to deliver analytical insights from months to minutes. Expert services support organizations in tailoring predictive models. This innovation aims to improve decision-making across various healthcare settings, addressing the industry's evolving challenges.
SOUTH JORDAN, Utah, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Health Catalyst (Nasdaq: HCAT) announced participation in upcoming investor conferences. Bryan Hunt, CFO, and Adam Brown, SVP of Investor Relations, will present at the Raymond James & Associates’ 42nd Annual Institutional Investors Conference on March 3, 2021, with a fireside chat at 12:30 p.m. EST. They will also participate in the 2021 Truist Securities Technology, Internet & Services Conference on March 9, 2021. Health Catalyst provides data and analytics technology to healthcare organizations to improve clinical, financial, and operational outcomes.
Health Catalyst (HCAT) reported its 2020 financial results, showcasing a 22% increase in total revenue, reaching $188.8 million. Technology revenue surged 32% year-over-year, driven by strong demand for data analytics amid the pandemic. Despite revenue growth, net losses ballooned by 202% to $43 million due to increased operational expenses. The company maintained a 102% dollar-based retention rate for its technology services, although professional services retention declined. Health Catalyst is optimistic about future growth, considering its robust technology usage during the health crisis.
Transformation Capital, a leader in digital health investments, announced the hiring of Jenna Ciotti as Vice President and Akhi Samant as Associate. Jenna, with experience at M33 Growth, will drive deal sourcing in digital health. She holds degrees from Yale University and focuses on improving health outcomes. Akhi, formerly at Goldman Sachs, brings expertise in technology and finance. Their addition aligns with Transformation's growth strategy and commitment to supporting innovative healthcare solutions, enhancing its impactful portfolio that includes notable companies like Health Catalyst (NASDAQ: HCAT).